Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 14, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
The Centers for Medicare and Medicaid Services issued a proposed decision memo detailing the coverage criteria for patients with Alzheimer disease to be covered by the federal health insurance platform when administered aducanumab (Aduhelm; Biogen)..
Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Anne-Maree Kelly, MD, MClinEd, FACEM, who shared her clinical experience treating patients with headache and migraine in the emergency department (ED), offering insight into the factors that influence patient outcomes and the vital need for consensus international guidelines for ED migraine care.
The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed why MR fingerprinting holds significant clinical potential in epilepsy and epilepsy-related disorders, and discussed how this approach is different from other typical standard MRIs, which may be limited in capacity for some forms of epilepsy.
Michael J. Thorpy, MD, ChB; Karl Doghramji, MD; Erinn E. Beagin, MD; Nathaniel Fletcher Watson, MD; and Vikas Jain, MD, FAASM, FAAFP, CCSH, CPE, offer a brief review of the value of polysomnography, or sleep studies, in diagnosing patients with insomnia, in episode 5 of this NeurologyLive® Peer Exchange, "Unmet Needs in Treating Insomnia."
The founder and CEO of Joi Wellness Group Multiple Sclerosis Center explained her experience with telemedicine in her practice and expressed her hope that telemedicine, as well as the collaborative approach within the comprehensive care model generated during the pandemic, are both here to stay.
Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.